|
|
Volumn 8, Issue 2, 2002, Pages 143-145
|
|
Editorial: Pros and cons of using interleukin-2 receptor antibodies in liver transplant recipients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCINEURIN INHIBITOR;
CD4 ANTIGEN;
CORTICOSTEROID;
CYCLOSPORIN;
CYCLOSPORIN A;
INTERLEUKIN 15;
INTERLEUKIN 2 RECEPTOR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
BASILIXIMAB;
HYBRID PROTEIN;
IMMUNOSUPPRESSIVE AGENT;
MONOCLONAL ANTIBODY;
BONE DISEASE;
CONTROLLED STUDY;
DIABETES MELLITUS;
DOSE RESPONSE;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
GRAFT REJECTION;
HEPATITIS C;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
PRIORITY JOURNAL;
RECIPIENT;
STANDARD;
IMMUNOLOGY;
NOTE;
RECURRENT DISEASE;
ANTIBODIES, MONOCLONAL;
HEPATITIS C;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
RECEPTORS, INTERLEUKIN-2;
RECOMBINANT FUSION PROTEINS;
RECURRENCE;
|
|
EID: 0036197425
PISSN: 15276465
EISSN: None
Source Type: Journal
DOI: 10.1053/jlts.2002.31384 Document Type: Article |
|
Times cited : (9)
|
|
References (13)
|
